Loading...
Stepan Company
SCL•NYSE
Basic Materials
Chemicals - Specialty
$57.05
$0.38(0.67%)
Stepan Company (SCL) Financial Performance & Income Statement Overview
Review Stepan Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-6.26%
↓ 6.26%
Operating Income Growth
20.25%
↑ 20.25%
Net Income Growth
25.29%
↑ 25.29%
Operating Cash Flow Growth
0.00%
Operating Margin
3.54%
↑ 3.54%
Gross Margin
12.48%
↑ 12.48%
Net Profit Margin
2.53%
↑ 2.53%
ROE
4.70%
↑ 4.70%
ROIC
4.76%
↑ 4.76%
Stepan Company (SCL) Income Statement & Financial Overview
Review Stepan Company's (SCL) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $525.61M | $546.84M | $556.40M | $551.42M |
Cost of Revenue | $468.91M | $471.16M | $486.86M | $481.14M |
Gross Profit | $56.70M | $75.69M | $69.55M | $70.28M |
Gross Profit Ratio | $0.11 | $0.14 | $0.12 | $0.13 |
R&D Expenses | $13.79M | $13.53M | $14.09M | $14.26M |
SG&A Expenses | $35.78M | $38.20M | $36.79M | $34.08M |
Operating Expenses | $49.001M | $51.74M | $50.88M | $48.33M |
Total Costs & Expenses | $517.91M | $522.89M | $537.74M | $529.47M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $3.62M | $0.00 | $0.00 |
Depreciation & Amortization | $28.52M | $28.06M | $28.01M | $27.60M |
EBITDA | $45.64M | $53.00M | $47.09M | $47.77M |
EBITDA Ratio | $0.09 | $0.10 | $0.08 | $0.09 |
Operating Income | $7.70M | $23.95M | $18.66M | $21.95M |
Operating Income Ratio | $0.01 | $0.04 | $0.03 | $0.04 |
Other Income/Expenses (Net) | -$5.24M | -$2.63M | -$1.46M | -$709000.00 |
Income Before Tax | $2.46M | $21.32M | $17.21M | $19.46M |
Income Before Tax Ratio | $0.005 | $0.04 | $0.03 | $0.04 |
Income Tax Expense | -$894000.00 | -$2.29M | $7.68M | $5.57M |
Net Income | $3.35M | $23.61M | $9.52M | $13.89M |
Net Income Ratio | $0.006 | $0.04 | $0.02 | $0.03 |
EPS | $0.15 | $1.03 | $0.42 | $0.61 |
Diluted EPS | $0.15 | $1.03 | $0.42 | $0.61 |
Weighted Avg Shares Outstanding | $22.84M | $22.84M | $22.83M | $22.82M |
Weighted Avg Shares Outstanding (Diluted) | $22.91M | $22.92M | $22.94M | $22.95M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan